Granules India Limited – FDA 483, Jun 20, 2025
Granules India Limited, an API manufacturer in Sangareddy District, Telangana, India, was cited for significant failures in documenting and investigating deviations from established procedures. Observations included the approval of a Quality Comparison Report with an incorrect drug name that went uninvestigated for an extended period, and uninvestigated out-of-specification differential pressure readings in a cleanroom corridor. These issues highlight deficiencies in the firm's quality system and deviation management.
ID · 20298bd3-98c2-4aa3-8184-529439bfb3c0
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.